Piper Sandler is a multinational investment bank focused on mergers and acquisitions, financial restructuring, public offerings, public finance, institutional brokerage, investment management, and securities research. The firm is benefiting from a recovery in biotech funding, robust M&A activity, and a resurgence in mid-market private equity.
Cyborg Score Rationale
In 2024, Piper Sandler's revenue was $1.53 billion, up 13.20% year-over-year, with earnings of $181.11 million, up 111.85%. Strong operational growth combined with strategic positioning in high-growth sectors like biotech and mid-market M&A demonstrates solid financial and competitive momentum.
Top Insights
Q3 2025 beat Wall Street expectations with 33.3% YoY revenue growth to $479.3M and 16.7% EPS beat
Strategic positioning in healthcare, biotech, and mid-market M&A benefiting from structural tailwinds
Diversified business model across advisory, capital markets, institutional brokerage, and public finance
128-year heritage (founded 1895) with 60+ offices globally, demonstrating proven resilience and scale
Named Competitors
Houlihan Lokey — Mid-market M&A and restructuring advisory
Evercore — Investment banking and equities research
Stifel — Investment banking and institutional brokerage
PJT Partners — M&A and strategic advisory
Recent Developments
(Feb 2026) Q4 2025 financial results announcement scheduled for February 6, 2026
(Q3 2025) Beat Wall Street with 33.3% YoY revenue growth and strong pre-tax profit margins
(Jan 2026) Named Michael Piper as head of fixed income effective Q1 2026
(Q3 2025) Launched private markets trading with new hires, expanding merchant banking capabilities
Open the full interactive Piper Sandler Companies report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.